InvestorsHub Logo

biopharm

10/30/16 9:59 PM

#277563 RE: biopharm #268020

Peregrine Pharmaceuticals PS Targeting seems to be Sean Parker like Manhattan Project....especially when one sees "private profile" involved and when Dr Troy Luster removes Evotec ties from his LinkedIn profile I naturally will dig deeper.... So CRISPR seems to be important, and gene editing must target flipped PS

hhttps://www.google.com/amp/singularityhub.com/2016/06/26/75-crispr-targets-cancer-in-first-human-trial-what-you-need-to-know/amp/?client=safari

"...strange proteins on their surface..." = sounds like flipped PS and net negative charges at the surface

Https://www.google.com/amp/amp.timeinc.net/fortune/2016/06/21/sean-parker-first-crispr-trial/%3Fsource%3Ddam?client=safari


biopharm

03/16/17 5:11 AM

#291217 RE: biopharm #268020

Private profiles on research gate with M Herrmann may be revealed within 30 days and a partner to Peregrine?
...
interesting times to be a long investor in Peregrine